Understand YIDU TECH (02158) 2026 financial results in one chart: full-year profit for the first time!

On July 2nd, China's leading AI healthcare company YIDU TECH (02158) held a financial performance conference for the 2026 fiscal year, interpreting its annual performance report ending on March 31, 2026. During the reporting period, the company achieved profitability for the first time in a year, with annual profit reaching RMB 78.766 million, exceeding the upper limit of the profit forecast net profit range of RMB 55-70 million; net profit attributable to shareholders reached RMB 72.709 million, approximately 30% higher than the upper limit of the estimated range of RMB 56 million. The company's total revenue for the year increased by 14.6% year-on-year to RMB 820 million, and adjusted EBITDA increased more than 4.6 times year-on-year to RMB 220 million. The quality of profitability has also improved, with the overall gross profit margin increasing from 33.5% in the same period last year to 36.4%. In the second half of the year, operating cash flow turned positive, recording RMB 29.3 million, indicating the profitability entering an upward trend. In terms of growth momentum, the core sectors saw strong performance in new orders. In particular, the AI for Medical sector saw a 22.3% year-on-year increase in new orders, while the AI for Life Sciences sector saw a 42% increase, providing clear visibility for future revenue growth.